Literature DB >> 718470

Malignant optic gliomas in adults.

C G Harper, E G Stewart-Wynne.   

Abstract

Malignant gliomas of the optic pathways are uncommon in adults and are rarely diagnosed in life. In three cases of such tumors, the diagnosis was not suspected during life. Neuropathological examination showed involvement of the optic nerves, chiasm, and tracts with extensive involvement of contiguous structures in all of the cases. In view of the consistent clinical features, it is stressed that in adults with progressive visual failure, malignant gliomas of the optic pathways be included in the differential diagnosis.

Entities:  

Mesh:

Year:  1978        PMID: 718470     DOI: 10.1001/archneur.1978.00500350035007

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  Glioblastoma of the optic pathways: An Atypical case.

Authors:  Rahat Brar; Abhishek Prasad; Manpreet Brar
Journal:  J Radiol Case Rep       Date:  2009-09-01

2.  Malignant chiasmal glioma: a rare cause of rapid visual loss.

Authors:  J M Valdueza; L Cristante; J Freitag; C Hagel; H D Herrmann
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

Review 3.  Unilateral adult malignant optic nerve glioma.

Authors:  Bettina Wabbels; Anke Demmler; Johannes Seitz; Matthias Woenckhaus; Heinz-Georg Bloss; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

4.  Glioblastoma in the optic chiasm: A case report.

Authors:  Lina F Merchancano-Esquivel; Carlos Felipe Marín-Díaz; Valentina Mejía-Quiñones; Ana María Granados-Sánchez
Journal:  Radiol Case Rep       Date:  2021-12-28

5.  Malignant optic glioma masked by suspected optic neuritis and central retinal vein occlusion.

Authors:  Aleksandrs Kalnins; Mrudula Penta; Tarek El-Sawy; Y Joyce Liao; Nancy Fischbein; Michael Iv
Journal:  Radiol Case Rep       Date:  2018-11-13

6.  Highly Expressed CYBRD1 Associated with Glioma Recurrence Regulates the Immune Response of Glioma Cells to Interferon.

Authors:  Mingjie Qing; Jiahao Zhou; Weijian Chen; Lijuan Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-16       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.